Kezar Life Sciences, Inc. (KZR) Restructuring Costs (2023 - 2026)

Kezar Life Sciences has reported Restructuring Costs for 4 years, with the latest figure at $600000.0 in Q1 2026.

• Quarterly Restructuring Costs changed N/A year-over-year to $600000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 49.66% YoY) and the FY2025 annual result came in at $1.6 million, up 8.84% from the prior year.
• Restructuring Costs declined to $600000.0 in Q1 2026 per KZR's latest filing, from $1.6 million in the prior quarter.
• Over five years, Restructuring Costs peaked at $6.2 million in Q4 2023 and troughed at -$12000.0 in Q4 2024.
• A 4-year average of $2.0 million and a median of $1.5 million in 2024 frame the typical range for Restructuring Costs.
• The sharpest annual moves came in 2024 and 2025: Restructuring Costs tumbled 100.19% in 2024, then soared 13433.33% in 2025.
• Over 4 years, Restructuring Costs stood at $6.2 million in 2023, then sank by 100.19% to -$12000.0 in 2024, then jumped by 13433.33% to $1.6 million in 2025, then slumped by 62.5% to $600000.0 in 2026.
• According to Business Quant data, Restructuring Costs over the past three periods registered $600000.0, $1.6 million, and -$12000.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.